| Dr James W Thompson, MD | |
|
3260 Hospital Dr, Juneau, AK 99801-7808 | |
| (907) 796-8427 | |
| Not Available |
| Full Name | Dr James W Thompson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 3260 Hospital Dr, Juneau, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518006832 | NPI | - | NPPES |
| A006 | Other | CHAMPUS | |
| 079 | Other | BLUE CROSS | |
| MD1296 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 1296 (Alaska) | Primary |
| Entity Name | Juneau Emergency Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912393356 PECOS PAC ID: 2466745351 Enrollment ID: O20160729002119 |
News Archive
University of Calgary Faculty of Kinesiology researcher Elias Tomaras says the idea came to him while watching track and field sprinters warm-up for a race. "If you watch sprinters, short distance speed skaters or cyclists before their race, they will often warm-up for one to two hours, including several brief bouts of high intensity exercise. From an exercise physiology point of view, it seemed like it might be pretty tiring."
Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified commensal bacteria in the human intestine that produce a neurotransmitter that may play a role in preventing or treating inflammatory bowel diseases such as Crohn's disease.
QR Pharma, Inc., a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer's disease and the Medical University of South Carolina (MUSC) announced today that they received a Small Business Innovation Research (SBIR) phase I grant in the amount of $220,000 to study Posiphen® and its metabolites in cell culture and in transgenic Alzheimer mice.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James W Thompson, MD 3260 Hospital Dr, Juneau, AK 99801-7808 Ph: (907) 796-8427 | Dr James W Thompson, MD 3260 Hospital Dr, Juneau, AK 99801-7808 Ph: (907) 796-8427 |
News Archive
University of Calgary Faculty of Kinesiology researcher Elias Tomaras says the idea came to him while watching track and field sprinters warm-up for a race. "If you watch sprinters, short distance speed skaters or cyclists before their race, they will often warm-up for one to two hours, including several brief bouts of high intensity exercise. From an exercise physiology point of view, it seemed like it might be pretty tiring."
Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.
Scientists have identified a gene that appears to play a significant role in raising a person's risk of having more severe subtypes of autism that co-occur with other genetic diseases, such as the chromosomal disorder 22q11.2 deletion syndrome.
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified commensal bacteria in the human intestine that produce a neurotransmitter that may play a role in preventing or treating inflammatory bowel diseases such as Crohn's disease.
QR Pharma, Inc., a clinical-stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of cognitive impairment and Alzheimer's disease and the Medical University of South Carolina (MUSC) announced today that they received a Small Business Innovation Research (SBIR) phase I grant in the amount of $220,000 to study Posiphen® and its metabolites in cell culture and in transgenic Alzheimer mice.
› Verified 1 days ago
Dr. Aric Brian Ludwig, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8427 | |
Dr. Alan Mcpherson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8427 | |
Dr. Norvin Perez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8505 Old Dairy Rd, Juneau, AK 99801 Phone: 907-790-4111 Fax: 907-790-3111 | |
Dr. Taylor Michael Dunn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Salmon Creek Ln, Juneau, AK 99801 Phone: 907-586-2434 | |
Dana Kerr, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8900 | |
Dr. Kenneth N Brown, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8427 |